Company Filing History:
Years Active: 2011-2017
Title: Ruggero De Maria: Innovator in Cancer Treatment
Introduction
Ruggero De Maria is a prominent inventor based in Rome, Italy, known for his significant contributions to cancer research. He holds three patents that focus on innovative methods for treating cancer through the use of antisense RNA. His work has the potential to change the landscape of cancer treatment and improve patient outcomes.
Latest Patents
Among his latest patents, Ruggero De Maria has developed antisense RNA for treating cancer and inhibiting metastasis. This patent provides methods for the treatment, diagnosis, and prophylaxis of cancer by administering antisense RNA, particularly miRs 15 and 16, to patients in need. His research emphasizes the importance of targeted therapies in combating cancer effectively.
Career Highlights
Ruggero has worked with esteemed institutions such as the Istituto Superiore di Sanità, where he has contributed to groundbreaking research in the field of oncology. His dedication to advancing cancer treatment has established him as a key figure in medical research.
Collaborations
Throughout his career, Ruggero has collaborated with notable colleagues, including Desiree Bonci and Ann Pegna Zeuner. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Ruggero De Maria's innovative work in cancer treatment through antisense RNA showcases his commitment to improving healthcare. His patents and collaborations reflect a dedication to advancing medical science and providing hope to patients battling cancer.